标题
Lipid control in patients with diabetes mellitus
作者
关键词
-
出版物
Nature Reviews Cardiology
Volume 8, Issue 5, Pages 278-290
出版商
Springer Nature
发表日期
2011-03-15
DOI
10.1038/nrcardio.2011.23
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
- (2010) Evan A. Stein et al. EUROPEAN HEART JOURNAL
- Balancing the benefits of statins versus a new risk—diabetes
- (2010) Christopher P Cannon LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) Helen M. Colhoun et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglycerides as vascular risk factors: new epidemiologic insights
- (2009) William B Kannel et al. CURRENT OPINION IN CARDIOLOGY
- Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
- (2009) Justin M.S. Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Niacin on Glucose Control in Patients With Dyslipidemia
- (2009) Ronald B. Goldberg et al. MAYO CLINIC PROCEEDINGS
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
- (2009) Allen J. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Discovery of Statins
- (2008) Thomas P. Stossel CELL
- Diabetic dyslipidemia and cardiovascular risk
- (2008) Robert H. Eckel Current Diabetes Reports
- The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2008) Connie B Newman et al. Diabetes & Vascular Disease Research
- Cardiovascular Disease in Diabetes
- (2008) Z. T. Bloomgarden DIABETES CARE
- Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study
- (2008) C. S. Fox et al. DIABETES CARE
- Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling
- (2008) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein Management in Patients With Cardiometabolic Risk
- (2008) John D. Brunzell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease
- (2008) James Shepherd et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
- (2008) Theodore Mazzone et al. LANCET
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
- (2008) Giovanni F M Strippoli et al. BMJ-British Medical Journal
- Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.
- (2007) John F. Paolini et al. AMERICAN JOURNAL OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started